Global Advanced Therapy Medicinal Products Market Size study, by Type (CAR-T Therapy, Gene Therapy, Cell Therapy and Tissue Engineered Product) and Regional Forecasts 2021-2027

  • Product Code:
    RP-ID-10347644
  • Published Date:
    6 Sep 2021
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

ccs

Market Overview:

Global Advanced Therapy Medicinal Products Market is valued approximately at USD 7.9 Million in 2020 and is anticipated to grow with a healthy growth rate of more than 13.2% over the forecast period 2021-2027. Advanced Therapy Medicinal Products have enabled the pharmaceutical industry and healthcare industry to open new modes for the treatment of incurable diseases and cancer types. The global Advanced Therapy Medicinal Products market is being driven by growing prevalence of diseases, an expanding healthcare industry and increasing research and development. For instance, in 2020, WuXi Advanced Therapies launched new closed process CAR-T Cell Therapy Platform to accelerate the timeframe for cell and gene therapy expansion, which is expected to boost the market growth. In 2020, EdiGene and Immunochina collaborated on Research & Development to develop allogeneic CAR-T therapy for cancer. Furthermore, the strategic development between hospitals and companies along with the government regulations and approvals will provide new opportunities for the global Advanced Therapy Medicinal Products industry. However, high manufacturing costs and low investments by the governments of less developed countries in the healthcare may impede market growth over the forecast period of 2021-2027.

In the regional analysis of the global Advanced Therapy Medicinal Products Market, North America is dominating the market while Asia-Pacific is expected to have the fastest growth rate among the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to growing demand for therapies in ambulatory centers and hospitals, technological progressions coupled with the well-established healthcare infrastructure which has stimulated product demand in the region. Whereas, high growth rate of Asia-Pacific can be attributed to the increasing number of cancer patients and people getting more aware due to government and private investments in improving healthcare infrastructure in the region.

Major market player included in this report are:
Spark Therapeutics, Inc.
Bluebird Bio, Inc.
Novartis AG
uniQure N.V.
Celgene Corporation
Gilead Lifesciences, Inc.
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
MEDIPOST
Vericel Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
CAR-T Therapy
Gene Therapy
Cell Therapy
Tissue Engineered Product

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Advanced Therapy Medicinal Products Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

Chapter 1.Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Advanced Therapy Medicinal Products Market , by Region, 2019-2027 (USD Billion)
1.2.2. Advanced Therapy Medicinal Products Market , by Type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Advanced Therapy Medicinal Products Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Advanced Therapy Medicinal Products Market Dynamics
3.1. Advanced Therapy Medicinal Products Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Expanding healthcare industry
3.1.1.2. Increasing research and development
3.1.2. Market Restraint
3.1.2.1. High manufacturing costs
3.1.2.2. Low investments by the governments of less developed countries in the healthcare
3.1.3. Market Opportunities
3.1.3.1. Strategic development between hospitals and companies
3.1.3.2. Government regulations and approvals
Chapter 4. Global Advanced Therapy Medicinal Products Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Advanced Therapy Medicinal Products Market, by Type
5.1. Market Snapshot
5.2. Global Advanced Therapy Medicinal Products Market by Type, Performance - Potential Analysis
5.3. Global Advanced Therapy Medicinal Products Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Advanced Therapy Medicinal Products Market , Sub Segment Analysis
5.4.1. CAR-T Therapy
5.4.2. Gene Therapy
5.4.3. Cell Therapy
5.4.4. Tissue Engineered Product
Chapter 6. Global Advanced Therapy Medicinal Products Market, Regional Analysis
6.1. Advanced Therapy Medicinal Products Market , Regional Market Snapshot
6.2. North America Advanced Therapy Medicinal Products Market
6.2.1. U.S. Advanced Therapy Medicinal Products Market
6.2.1.1. Type breakdown estimates & forecasts, 2018-2027
6.2.2. Canada Advanced Therapy Medicinal Products Market
6.3. Europe Advanced Therapy Medicinal Products Market Snapshot
6.3.1. U.K. Advanced Therapy Medicinal Products Market
6.3.2. Germany Advanced Therapy Medicinal Products Market
6.3.3. France Advanced Therapy Medicinal Products Market
6.3.4. Spain Advanced Therapy Medicinal Products Market
6.3.5. Italy Advanced Therapy Medicinal Products Market
6.3.6. Rest of Europe Advanced Therapy Medicinal Products Market
6.4. Asia-Pacific Advanced Therapy Medicinal Products Market Snapshot
6.4.1. China Advanced Therapy Medicinal Products Market
6.4.2. India Advanced Therapy Medicinal Products Market
6.4.3. Japan Advanced Therapy Medicinal Products Market
6.4.4. Australia Advanced Therapy Medicinal Products Market
6.4.5. South Korea Advanced Therapy Medicinal Products Market
6.4.6. Rest of Asia Pacific Advanced Therapy Medicinal Products Market
6.5. Latin America Advanced Therapy Medicinal Products Market Snapshot
6.5.1. Brazil Advanced Therapy Medicinal Products Market
6.5.2. Mexico Advanced Therapy Medicinal Products Market
6.6. Rest of The World Advanced Therapy Medicinal Products Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Spark Therapeutics, Inc.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Bluebird Bio, Inc.
7.2.3. Novartis AG
7.2.4. uniQure N.V.
7.2.5. Celgene Corporation
7.2.6. Gilead Lifesciences, Inc.
7.2.7. Kolon TissueGene, Inc.
7.2.8. JCR Pharmaceuticals Co., Ltd.
7.2.9. MEDIPOST
7.2.10. Vericel Corporation
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Spark Therapeutics, Inc.
Bluebird Bio, Inc.
Novartis AG
uniQure N.V.
Celgene Corporation
Gilead Lifesciences, Inc.
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
MEDIPOST
Vericel Corporation

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports